Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models

Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models

Potential impact of new tuberculosis vaccines in China, South Africa and India and implications for vaccine development

Files for modelling impact of TB vaccines 

Cost-effectiveness of routine adolescent vaccination with an M72/AS01E-like tuberculosis vaccine in South Africa and India

Abstract The M72/AS01 E tuberculosis vaccine showed 50% (95%CI: 2–74%) efficacy in a phase 2B tria

Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis

Abstract Early trials of novel vaccines against tuberculosis (TB) in adults have suggested substant

Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study

Planned, ongoing and completed tuberculosis treatment trials in Brazil, Russia, India, China and South Africa: a 2019 cross-sectional descriptive analysis

Tuberculosis (TB) remains a deadly challenge globally and Brazil, Russia, India, China and South Afr